Association and virulence gene expression vary among serotype III group B Streptococcus isolates following exposure to decidual and lung epithelial cells

Infection and Immunity

Volumn 82, Issue 11, 2014, Pages 4587-4595

  Korir, Michelle L ^a   Knupp, David ^a   LeMerise, Kathryn ^a   Boldenow, Erica ^b   Loch Caruso, Rita ^b   Aronoff, David M ^c   Manning, Shannon D ^a  

^a Department of Microbiology and Molecular Genetics Michigan State University ^*  (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL RNA;

AMNION CELL; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; CELL INVASION; CELL TYPE; CONTROLLED STUDY; DECIDUA; DECIDUALIZATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC TRAIT; GROUP B STREPTOCOCCAL INFECTION; GROWTH RATE; HOST CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFECTION PREVENTION; LUNG ALVEOLUS EPITHELIUM; NEWBORN; NONHUMAN; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; SEROTYPE; STREPTOCOCCUS AGALACTIAE; CELL LINE; CLASSIFICATION; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; LUNG; METABOLISM; PATHOGENICITY; PHYSIOLOGY; VIRULENCE;

CELL LINE; DECIDUA; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; LUNG; STREPTOCOCCUS AGALACTIAE; VIRULENCE;

EID: 84907959196     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02181-14     Document Type: Article

References (44)

1. Tudela CM, Stewart RD, Roberts SW, Wendel GD, Jr, Stafford IA, McIntire DD, Sheffield JS. 2012. Intrapartum evidence of early-onset group B Streptococcus. Obstet. Gynecol. 119:626-629. http://dx.doi.org/10.1097/AOG.0b013e31824532f6.
2. Doran KS, Nizet V. 2004. Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy. Mol. Microbiol. 54:23-31. http://dx.doi.org/10.1111/j.1365-2958.2004.04266.x.
3. Johri AK, Paoletti LC, Glaser P, Dua M, Sharma PK, Grandi G, Rappuoli R. 2006. Group B Streptococcus: global incidence and vaccine development. Nat. Rev. Microbiol. 4:932-942. http://dx.doi.org/10.1038/nrmicro1552.
4. Slotved H-C, Kong F, Lambertsen L, Sauer S, Gilbert GL. 2007. Serotype IX, a proposed new Streptococcus agalactiae serotype. J. Clin. Microbiol. 45:2929-2936. http://dx.doi.org/10.1128/JCM.00117-07.
5. Jones N, Bohnsack JF, Takahashi S, Oliver KA, Chan MS, Kunst F, Glaser P, Rusniok C, Crook DW, Harding RM, Bisharat N, Spratt BG. 2003. Multilocus sequence typing system for group B Streptococcus. J. Clin. Microbiol. 41:2530-2536. http://dx.doi.org/10.1128/JCM.41.6.2530-2536.2003.
6. Bohnsack JF, Whiting A, Gottschalk M, Dunn DM, Weiss R, Azimi PH, Philips JB, III, Weisman LE, Rhoads GG, Lin F-YC. 2008. Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999. J. Clin. Microbiol. 46:1285-1291. http://dx.doi.org/10.1128/JCM.02105-07.
7. Lin FC, Whiting A, Adderson E, Takahashi S, Dunn DM, Weiss R, Azimi PH, Philips JB, III, Weisman LE, Regan J, Clark P, Rhoads GG, Frasch CE, Troendle J, Moyer P, Bohnsack JF. 2006. Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective study. J. Clin. Microbiol. 44:1257-1261. http://dx.doi.org/10.1128/JCM.44.4.1257-1261.2006.
8. Luan S, Granlund M, Sellin M, Lagergård T, Spratt BG, Norgren M. 2005. Multilocus sequence typing of Swedish invasive group B Streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J. Clin. Microbiol. 43:3727-3733. http://dx.doi.org/10.1128/JCM.43.8.3727-3733.2005.
9. Manning SD, Springman AC, Lehotzky E, Lewis MA, Whittam TS, Davies HD. 2009. Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J. Clin. Microbiol. 47:1143-1148. http://dx.doi.org/10.1128/JCM.01424-08.
10. Maisey HC, Doran KS, Nizet V. 2008. Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev. Mol. Med. 10:e27. http://dx.doi.org/10.1017/S1462399408000811.
11. Sharma P, Lata H, Arya DK, Kashyap AK, Kumar H, Dua M, Ali A, Johri AK. 2013. Role of pilus proteins in adherence and invasion of Streptococcus agalactiae to the lung and cervical epithelial cells. J. Biol. Chem. 288:4023-4034. http://dx.doi.org/10.1074/jbc.M112.425728.
12. Rubens CE, Smith S, Hulse M, Chi EY, van Belle G. 1992. Respiratory epithelial cell invasion by group B streptococci. Infect. Immun. 60:5157-5163.
13. Schubert A, Zakikhany K, Pietrocola G, Meinke A, Speziale P, Eikmanns BJ, Reinscheid DJ. 2004. The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells. Infect. Immun. 72:6197-6205. http://dx.doi.org/10.1128/IAI.72.11.6197-6205.2004.
14. Winram SB, Jonas M, Chi E, Rubens CE. 1998. Characterization of group B Streptococcal invasion of human chorion and amnion epithelial cells in vitro. Infect. Immun. 66:4932-4941.
15. Gibson RL, Lee MK, Soderland C, Chi EY, Rubens CE. 1993. Group B streptococci invade endothelial cells: type III capsular polysaccharide attenuates invasion. Infect. Immun. 61:478-485.
16. Nizet V, Kim KS, Stins M, Jonas M, Chi EY, Nguyen D, Rubens CE. 1997. Invasion of brain microvascular endothelial cells by group B streptococci. Infect. Immun. 65:5074-5081.
17. Cieslewicz MJ, Chaffin D, Glusman G, Kasper D, Madan A, Rodrigues S, Fahey J, Wessels MR, Rubens CE. 2005. Structural and genetic diversity of group B Streptococcus capsular polysaccharides. Infect. Immun. 73:3096-3103. http://dx.doi.org/10.1128/IAI.73.5.3096-3103.2005.
18. Davies HD, Jones N, Whittam TS, Elsayed S, Bisharat N, Baker CJ. 2004. Multilocus sequence typing of serotype III group B Streptococcus and correlation with pathogenic potential. J. Infect. Dis. 189:1097-1102. http://dx.doi.org/10.1086/382087.
19. Spaetgens R, DeBella K, Ma D, Robertson S, Mucenski M, Davies HD. 2002. Perinatal antibiotic usage and changes in colonization and resistance rates of group B Streptococcus and other pathogens. Obstet. Gynecol. 100:525-533. http://dx.doi.org/10.1016/S0029-7844(02)02068-9.
20. Davies HD, Raj S, Adair C, Robinson J, McGeer A. 2001. Populationbased active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. Pediatr. Infect. Dis. J. 20:879-884. http://dx.doi.org/10.1097/00006454-200109000-00011.
21. Brosens JJ, Takeda S, Acevedo C, Lewis MP, Kirby PL, Symes EK, Krausz T, Purohit A, Gellersen B, White JO. 1996. Human endometrial fibroblasts immortalized by simian virus 40 large T antigen differentiate in response to a decidualization stimulus. Endocrinology 137:2225-2231.
22. Boldenow E, Jones S, Lieberman RW, Chames MC, Aronoff DM, Xi C, Loch-Caruso R. 2013. Antimicrobial peptide response to group B Streptococcus in human extraplacental membranes in culture. Placenta 34:480-485. http://dx.doi.org/10.1016/j.placenta.2013.02.010.
23. Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U. 2007. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol. Reprod. 77:577-588. http://dx.doi.org/10.1095/biolreprod.106.055244.
24. Pratama G, Vaghjiani V, Tee JY, Liu YH, Chan J, Tan C, Murthi P, Gargett C, Manuelpillai U. 2011. Changes in culture expanded human amniotic epithelial cells: implications for potential therapeutic applications. PLoS One 6:e26136. http://dx.doi.org/10.1371/journal.pone.0026136.
25. Liu T, Cheng W, Liu T, Guo L, Huang Q, Jiang L, Du X, Xu F, Liu Z, Lai D. 2010. Human amniotic epithelial cell feeder layers maintain mouse embryonic stem cell pluripotency via epigenetic regulation of the c-Myc promoter. Acta Biochim. Biophys. Sin. (Shanghai) 42:109-115. http://dx.doi.org/10.1093/abbs/gmp115.
26. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3:1101-1108. http://dx.doi.org/10.1038/nprot.2008.73.
27. Malin G, Paoletti LC. 2001. Use of a dynamic in vitro attachment and invasion system (DIVAS) to determine influence of growth rate on invasion of respiratory epithelial cells by group B Streptococcus. Proc. Natl. Acad. Sci. U. S. A. 98:13335-13340. http://dx.doi.org/10.1073/pnas.241079098.
28. Tazi A, Disson O, Bellais S, Bouaboud A, Dmytruk N, Dramsi S, Mistou M-Y, Khun H, Mechler C, Tardieux I, Trieu-Cuot P, Lecuit M, Poyart C. 2010. The surface protein HvgA mediates group B Streptococcus hypervirulence and meningeal tropism in neonates. J. Exp. Med. 207:2313-2322. http://dx.doi.org/10.1084/jem.20092594.
29. Kim KS. 2008. Mechanisms of microbial traversal of the blood-brain barrier. Nat. Rev. Microbiol. 6:625-634. http://dx.doi.org/10.1038/nrmicro1952.
30. Soriani M, Santi I, Taddei A, Rappuoli R, Grandi G, Telford JL. 2006. Group B Streptococcus crosses human epithelial cells by a paracellular route. J. Infect. Dis. 193:241-250. http://dx.doi.org/10.1086/498982.
31. Rajagopal L. 2009. Understanding the regulation of group B streptococcal virulence factors. Future Microbiol. 4:201-221. http://dx.doi.org/10.2217/17460913.4.2.201.
32. Spellerberg B, Rozdzinski E, Martin S, Weber-Heynemann J, Schnitzler N, Lütticken R, Podbielski A. 1999. Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin. Infect. Immun. 67:871-878.
33. Cheng Q, Stafslien D, Purushothaman SS, Cleary P. 2002. The group B streptococcal C5a peptidase is both a specific protease and an invasin. Infect. Immun. 70:2408-2413. http://dx.doi.org/10.1128/IAI.70.5.2408-2413.2002.
34. Seepersaud R, Hanniffy SB, Mayne P, Sizer P, Le Page R, Wells JM. 2005. Characterization of a novel leucine-rich repeat protein antigen from group B Streptococci that elicits protective immunity. Infect. Immun. 73:1671-1683. http://dx.doi.org/10.1128/IAI.73.3.1671-1683.2005.
35. Brodeur BR, Boyer M, Charlebois I, Hamel J, Couture F, Martin D. 2000. Identification of group B streptococcal Sip protein, which elicits cross-protective immunity. Infect. Immun. 68:5610-5618. http://dx.doi.org/10.1128/IAI.68.10.5610-5618.2000.
36. Gutekunst H, Eikmanns BJ, Reinscheid DJ. 2004. The novel fibrinogenbinding protein FbsB promotes Streptococcus agalactiae invasion into epithelial cells. Infect. Immun. 72:3495-3504. http://dx.doi.org/10.1128/IAI.72.6.3495-3504.2004.
37. Tettelin H, Masignani V, Cieslewicz MJ, Donati C, Medini D, Ward NL, Angiuoli SV, Crabtree J, Jones AL, Durkin AS, Deboy RT, Davidsen TM, Mora M, Scarselli M, Margarit y Ros I, Peterson JD, Hauser CR, Sundaram JP, Nelson WC, Madupu R, Brinkac LM, Dodson RJ, Rosovitz MJ, Sullivan SA, Daugherty SC, Haft DH, Selengut J, Gwinn ML, Zhou L, Zafar N, Khouri H, Radune D, Dimitrov G, Watkins K, O'Connor KJ, Smith S, Utterback TR, White O, Rubens CE, Grandi G, Madoff LC, Kasper DL, Telford JL, Wessels MR, Rappuoli R, Fraser CM. 2005. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc. Natl. Acad. Sci. U. S. A. 102:13950-13955. http://dx.doi.org/10.1073/pnas.0506758102.
38. Seifert KN, Adderson EE, Whiting AA, Bohnsack JF, Crowley PJ, Brady LJ. 2006. A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae. Microbiology 152:1029-1040. http://dx.doi.org/10.1099/mic.0.28516-0.
39. Samen U, Eikmanns BJ, Reinscheid DJ, Borges F. 2007. The surface protein Srr-1 of Streptococcus agalactiae binds human keratin 4 and promotes adherence to epithelial HEp-2 cells. Infect. Immun. 75:5405-5414. http://dx.doi.org/10.1128/IAI.00717-07.
40. Santi I, Scarselli M, Mariani M, Pezzicoli A, Masignani V, Taddei A, Grandi G, Telford JL, Soriani M. 2007. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood. Mol. Microbiol. 63:754-767. http://dx.doi.org/10.1111/j.1365-2958.2006.05555.x.
41. Chattopadhyay D, Carey AJ, Caliot E, Webb RI, Layton JR, Wang Y, Bohnsack JF, Adderson EE, Ulett GC. 2011. Phylogenetic lineage and pilus protein Spb1/SAN1518 affect opsonin-independent phagocytosis and intracellular survival of group B Streptococcus. Microbes Infect. 13:369-382. http://dx.doi.org/10.1016/j.micinf.2010.12.009.
42. Adderson EE, Takahashi S, Wang Y, Armstrong J, Miller DV, Bohnsack JF. 2003. Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae. Infect. Immun. 71:6857-6863. http://dx.doi.org/10.1128/IAI.71.12.6857-6863.2003.
43. Whidbey C, Harrell MI, Burnside K, Ngo L, Becraft AK, Iyer LM, Aravind L, Hitti J, Waldorf KMA, Rajagopal L. 2013. A hemolytic pigment of group B Streptococcus allows bacterial penetration of human placenta. J. Exp. Med. 210:1265-1281. http://dx.doi.org/10.1084/jem.20122753.
44. Doran KS, Engelson EJ, Khosravi A, Maisey HC, Fedtke I, Equils O, Michelsen KS, Arditi M, Peschel A, Nizet V. 2005. Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J. Clin. Invest. 115:2499-2507. http://dx.doi.org/10.1172/JCI23829.